These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8978921)

  • 1. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 2. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the neurovirulence test for mumps vaccines.
    Afzal MA; Marsden SA; Hull RM; Pipkin PA; Bentley ML; Minor PD
    Biologicals; 1999 Mar; 27(1):43-9. PubMed ID: 10441402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unsuitability of the neurovirulence test for assessing the safety of vaccinal strains of the mumps virus].
    Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():101-3. PubMed ID: 262708
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
    Rozina EE; Hilgenfeldt M
    Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.
    Rubin SA; Amexis G; Pletnikov M; Li Z; Vanderzanden J; Mauldin J; Sauder C; Malik T; Chumakov K; Carbone KM
    J Virol; 2003 Nov; 77(21):11616-24. PubMed ID: 14557647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.
    Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA
    Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and development of a promising novel mumps vaccine candidate strain.
    Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
    Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].
    Ignat'ev GM; Otrashevskaia EV; Rubin SA
    Vopr Virusol; 2011; 56(4):30-3. PubMed ID: 21899067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Ivancic-Jelecki J; Forcic D; Jagusic M; Kosutic-Gulija T; Mazuran R; Balija ML; Isakov O; Shomron N
    Vaccine; 2016 Apr; 34(20):2383-9. PubMed ID: 27013432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.
    Rubin SA; Pletnikov M; Carbone KM
    J Virol; 1998 Oct; 72(10):8037-42. PubMed ID: 9733843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino "wild" strain of mumps virus.
    Sasaki K; Higashihara M; Inoue K; Igarashi Y; Makino S
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):43-52. PubMed ID: 828947
    [No Abstract]   [Full Text] [Related]  

  • 19. Aseptic meningitis after transmission of the Leningrad-Zagreb mumps vaccine from vaccinee to susceptible contact.
    Vukić BT; Pavić I; Milotić I; Slavuljica I
    Vaccine; 2008 Sep; 26(38):4879. PubMed ID: 18639602
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the behaviour of the mumps virus in different cell culture systems.
    Clucerescu V; Babeş L; Găleşanu M
    Roum Arch Microbiol Immunol; 1992; 51(3):131-5. PubMed ID: 1297460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.